The quick run up I did this morning. Very conservative with lower than guidance production and higher costs. 0 expectations for mcphillamies. Return on capital 9‰ at current prices which is pretty solid to me atm compared to cost of money, property yields etc.
If I use middle guidance of 485k Oz, 1360aisc, at current prices the 'yield' jumps to almost 12‰. Still allows for zero upside for mcphillamies.
Valuation at $3 a share results in just shy of 9% yield and very doable. More upside exists if we tack on 200k production from mcphillamys.
All its assets in Australia which is huge benefit. All based on a flat aud gold price, while I think we will be challenging the highs within 12 months given monetary and fiscal outlook around the world.
Edited to add: also treats capital as a straight up expense which obviously isn't true either, but good enough for simple review and it's very conservative to treat it this way.![]()
- Forums
- ASX - By Stock
- Under valued
RRL
regis resources limited
Add to My Watchlist
1.54%
!
$4.49

The quick run up I did this morning. Very conservative with...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.49 |
Change
-0.070(1.54%) |
Mkt cap ! $3.392B |
Open | High | Low | Value | Volume |
$4.54 | $4.54 | $4.45 | $14.40M | 3.212M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2269 | $4.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.50 | 55705 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 44961 | 4.450 |
3 | 33384 | 4.440 |
2 | 20784 | 4.430 |
1 | 2272 | 4.400 |
1 | 500 | 4.390 |
Price($) | Vol. | No. |
---|---|---|
4.500 | 55705 | 3 |
4.510 | 28718 | 2 |
4.520 | 16651 | 2 |
4.550 | 1000 | 1 |
4.580 | 6000 | 1 |
Last trade - 16.12pm 26/06/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online